Switzerland · Funded startup
Funding summaryUpdated 26 Oct 2026
$646Mraised across 7 rounds since 2013, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Pulse 2.0
Redmile Group
AstraZeneca
Auven TherapeuticsReported by FinSMEs
From ADC Therapeutics's own website: 10 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Auven TherapeuticsRedmile Group
TCG CrossoverAstraZeneca
Deerfield
TCGBain Capital Life SciencesMedImmune VenturesRedmileNantahala CapitalMissing a round, or an investor who was in one? Tell us.
ADC Therapeutics's investors include Auven Therapeutics, Redmile Group, TCG Crossover, AstraZeneca and Deerfield, and 6 more on record.
ADC Therapeutics has raised $646M across 7 rounds since 2013.
ADC Therapeutics's most recent round was an Undisclosed round of $87M in Oct 2026.
ADC Therapeutics's largest round on record is $200M (Undisclosed round), in Oct 2017.
ADC Therapeutics's first round on record, in Oct 2013, was backed by MedImmune Ventures and Auven Therapeutics.
ADC Therapeutics's latest named round is an Undisclosed round, in Oct 2026.
ADC Therapeutics is based in Switzerland.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Switzerland · 
